Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.

Insulin pump therapy, also known as continuous subcutaneous ... including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which advises multiple health ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

Looking at the universe of stocks we cover at Dividend Channel, on 12/27/24, Medtronic PLC (Symbol: MDT), DENTSPLY SIRONA Inc (Symbol: XRAY), and Danaher Corp (Symbol: DHR) will all trade ex ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Each participant used an insulin pump for three months or longer, and their estimated HbA1c was 11% or less. The selected participants were asked to use birth control or actively avoid pregnancy ...

2 For people with diabetes who do not have an insulin pump, calculating the appropriate bolus dose can present a challenge for them and their physicians. With the Glooko platform, patients can ...